| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 01/15/2014 | EP2683695A1 Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives |
| 01/15/2014 | EP2683694A1 Androgen receptor antagonists and uses thereof |
| 01/15/2014 | EP2683688A1 Indolecarboxamides and benzimidazolecarboxamides as insecticides and acaricides |
| 01/15/2014 | CN103508960A Benzoheterocyclic derivatives |
| 01/15/2014 | CN103508940A 6, 6-disubstituted-6-H-benzo[cd]pyrene derivatives and intermediates, and preparation methods and applications of derivatives and intermediates |
| 01/15/2014 | CN103508930A Bis(aminodithioformate)-1,3-propane diester compound, and synthesis method, pharmaceutical composition and use thereof |
| 01/15/2014 | CN102676275B Lubricating oil additive as well as preparation method and application thereof |
| 01/15/2014 | CN102532035B Method for synthesizing azoic coupling component AS-BI |
| 01/09/2014 | WO2014007228A1 Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes |
| 01/08/2014 | EP2681201A1 A method of manufacturing 2-ethoxy-1-((2'-((hydroxyamino) iminomethyl)biphenyl-4- yl)methyl)-1h-benzo [d]imidazole-7-carboxylic acid and its esters |
| 01/08/2014 | EP2681200A1 Benzimidazole inhibitors of the sodium channel |
| 01/08/2014 | CN103502223A Benzoimidazole derivatives for use in light - emitting devices |
| 01/08/2014 | CN103502216A Indolecarboxamides and benzimidazolecarboxamides as insecticides and acaricides |
| 01/08/2014 | CN103497114A NMDA receptor antagonists for neuroprotection |
| 01/08/2014 | CN102442952B Cyclic N-heterocyclic carbene metal complex, and preparation method and application thereof |
| 01/03/2014 | WO2014000694A1 Phendioxin heterocycle derivative |
| 01/02/2014 | US20140005240 Compounds and compositions for use as modulators of tau aggregation and alleviation of tauopathies |
| 01/02/2014 | US20140005221 Ring-fused compound |
| 01/02/2014 | US20140005194 Benzimidazole derivatives: preparation and pharmaceutical applications |
| 01/02/2014 | US20140005164 Wnt pathway antagonists |
| 01/01/2014 | EP2678319A2 Antibiotic tolerance inhibitors |
| 01/01/2014 | EP2678316A2 Substituted aromatic sulfur compounds and methods of their use |
| 01/01/2014 | CN103483267A Diverse arylimidazole quaternary ammonium salt, preparation method and application thereof |
| 01/01/2014 | CN103483266A Synthesis method of 2-substituted benzimidazole compound |
| 12/31/2013 | US8618150 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators |
| 12/27/2013 | WO2013190301A1 Cycloalkyl ether compounds and their use as bace inhibitors |
| 12/27/2013 | WO2013190299A1 Cyclohexane-1,2'-indene-1',2"-imidazol compounds and their use as bace inhibitors |
| 12/27/2013 | WO2013190298A1 2h-imidazol-4-amine compounds and their use as bace inhibitors |
| 12/27/2013 | WO2013189847A1 Bendamustine derivatives and related compounds, and medical use thereof cancer therapy |
| 12/27/2013 | WO2013018095A8 Compounds and compositions for use in augmentation of glucose uptake and insulin secretion |
| 12/27/2013 | WO2012162635A8 Metabotropic glutamate receptors 5 modulators and methods of use thereof |
| 12/27/2013 | CA2875588A1 Cyclohexane-1,2'-indene-1',2"-imidazole compounds and their use as bace inhibitors |
| 12/27/2013 | CA2875494A1 2h-imidazol-4-amine compounds and their use as bace inhibitors |
| 12/27/2013 | CA2875455A1 Bendamustine derivatives and related compounds, and medical use thereof cancer therapy |
| 12/27/2013 | CA2874950A1 Cycloalkyl ether compounds and their use as bace inhibitors |
| 12/26/2013 | US20130345436 method for preparing 2-(N-substituted)-amino-benzimidazole derivatives |
| 12/26/2013 | US20130345272 Cycloalkyl Ether Compounds and Their Use as Bace Inhibitors |
| 12/26/2013 | US20130345261 Benzimidazole inhibition of biofilm formation |
| 12/26/2013 | US20130345248 Cyclohexane-1,2'-Naphthalene-1',2"-Imidazol Compounds and Their Use as Bace |
| 12/26/2013 | US20130345247 Cyclohexane-1,2'-Indene-1',2"-Imidazol Compounds and Their Use as Bace Inhibitors |
| 12/26/2013 | US20130345246 2H-Imidazol-4-Amine Compounds and Their Use as Bace Inhibitors |
| 12/25/2013 | EP2152670B1 Bridged six-membered ring compounds |
| 12/25/2013 | CN103476758A A method of manufacturing 2-ethoxy-1-((2'-((hydroxyamino) iminomethyl)biphenyl-4- yl)methyl)-1h-benzo [d] imidazole-7-carboxylic acid and its esters |
| 12/25/2013 | CN103476752A Substituted aromatic sulfur compounds and methods of their use |
| 12/25/2013 | CN103468245A OLED material with carrier transmittability as well as preparation method and application thereof |
| 12/24/2013 | CA2706858C Imidazole and triazole derivatives and methods of use |
| 12/24/2013 | CA2660383C Pharmacologically active disulfide compounds |
| 12/24/2013 | CA2565200C Raf modulators and methods of use |
| 12/19/2013 | WO2013186332A1 4 - substituted 1, 3 - dihydro - 2h - benzimidazol - 2 - one derivatives substituted with benzimidazoles as respiratory syncytial virus antiviral agents |
| 12/19/2013 | WO2013186229A1 Tnf -alpha modulating benzimidazoles |
| 12/19/2013 | WO2013150545A3 Process for preparation of benzimidazole derivatives and salts thereof |
| 12/18/2013 | CN103459551A Phototherapy devices and methods comprising optionally substituted terphenyl and quaterphenyl compounds |
| 12/18/2013 | CN103450112A N-bridge connected nitrogenous five-membered heterocyclic compound and preparation and application thereof |
| 12/18/2013 | CN103450093A 2-aminobenzimidazoles and applications thereof |
| 12/18/2013 | CN103449947A Pre-purification method before sublimation and purification of OLED (organic light emitting diode) material |
| 12/17/2013 | US8609864 Hydroxamic acid derivatives |
| 12/17/2013 | US8609863 Bendamustine pharmaceutical compositions |
| 12/17/2013 | US8609862 Use of an adrenal hormone-modifying agent |
| 12/17/2013 | US8609656 Heteroarylphenylurea derivative |
| 12/12/2013 | WO2013184766A1 Compounds and compositions for modulating egfr activity |
| 12/12/2013 | WO2013182046A1 Organic electronic material and organic electroluminescent device |
| 12/11/2013 | EP2672540A1 Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same |
| 12/11/2013 | EP2670735A1 Methods for the preparation of bendamustine |
| 12/11/2013 | CN103443084A Methods for preparing bendamustine |
| 12/11/2013 | CN103436048A Double-bridge-chain organic dye using thiourea as donor and application thereof |
| 12/11/2013 | CN103435554A 2-phenylaminobenzimidazole compound and application thereof |
| 12/11/2013 | CN103435553A Piperazine structure-based aryl formamide Raf kinase inhibitor and preparation method as well as application thereof |
| 12/11/2013 | CN103435552A 1,2-disubstituted benzimidazole compound preparation method |
| 12/11/2013 | CN103435551A 2-substituted benzimidazole compound preparation method |
| 12/11/2013 | CN103435550A Tanshinone derivative, preparation method and application thereof |
| 12/11/2013 | CN102153538B Benzocyclodirivative |
| 12/05/2013 | WO2013178815A1 Bicyclic heterocycles capable of modulating t-cell responses, and methods of using same |
| 12/05/2013 | US20130324537 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors |
| 12/05/2013 | CA2874919A1 Bicyclic heterocycles capable of modulating t-cell responses, and methods of using same |
| 12/04/2013 | EP2669275A1 Capsule-type compound, anion-removing agent, and anion removal method |
| 12/04/2013 | EP2669270A1 Ring-fused compound |
| 12/04/2013 | EP2668247A1 Phototherapy devices and methods comprising optionally substituted terphenyl and quaterphenyl compounds |
| 12/04/2013 | EP2667868A2 Bendamustine formulations |
| 12/04/2013 | EP2530071B1 Fused polycyclic compound and organic light-emitting device using the compound |
| 12/04/2013 | CN103429573A Cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives |
| 12/04/2013 | CN103420917A Benzamide compounds containing fused ring structure and applications thereof as antitumor medicaments |
| 12/04/2013 | CN103420749A Green synthesis method of thiourea derivative |
| 12/03/2013 | US8598196 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy |
| 12/03/2013 | US8598183 Solid state forms of a potent HCV inhibitor |
| 12/03/2013 | US8598181 Modulators of ATP-binding cassette transporters |
| 12/03/2013 | US8598148 Synthesis of tetracyclines and analogues thereof |
| 12/03/2013 | US8598078 Condensed anthran I lami de derivatives as insecticides |
| 12/03/2013 | US8597903 Biotinidase assay |
| 12/03/2013 | CA2516660C Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 11/28/2013 | WO2013177539A1 Compounds, sensors, methods, and systems for detecting gamma radiation |
| 11/28/2013 | WO2013175746A1 Organic electroluminescent element |
| 11/28/2013 | US20130317234 Process for Preparation of Intermediates of Bendamustine |
| 11/28/2013 | US20130317027 Compounds and therapeutic uses thereof |
| 11/27/2013 | CN103408500A Preparation method for angiotensin II receptor blocker and key intermediate thereof |
| 11/26/2013 | CA2335240C Cyanine dyes and synthesis methods thereof |
| 11/21/2013 | WO2013170758A1 Fused ring-structured benzamide compound and application thereof as antineoplastic medicament |
| 11/21/2013 | WO2013155483A8 Phototherapy devices and methods comprising optionally substituted quinquiesphenyl compounds |
| 11/21/2013 | US20130310571 Methods for the preparation of bendamustine |
| 11/20/2013 | EP2468717B1 Heterocyclic Amide Compounds Useful as Kinase Inhibitors |
| 11/20/2013 | EP2350022B1 New benzimidazole derivatives |